| Kodiak Sciences Inc | 1.09M | US$103M | 4.3% |
| Caris Life Sciences, Inc. | 2.75M | US$84.1M | 3.5% |
| Edgewise Therapeutics, Inc. | 2.07M | US$84M | 3.5% |
| Alphatec Holdings, Inc. | 7.23M | US$74.6M | 3.1% |
| iRhythm Holdings, Inc. | 641K | US$72.8M | 3.0% |
| Hinge Health, Inc. | 655K | US$63.7M | 2.6% |
| Spyre Therapeutics, Inc. | 714K | US$63.6M | 2.6% |
| Xenon Pharmaceuticals Inc. | 1.71M | US$63.5M | 2.6% |
| NeoGenomics, Inc. | 3.35M | US$61.5M | 2.6% |
| Glaukos Corporation | 344K | US$56.5M | 2.3% |
| Vera Therapeutics, Inc. | 1.73M | US$55.8M | 2.3% |
| TransMedics Group, Inc. | 654K | US$54.6M | 2.3% |
| Intuitive Surgical, Inc. | 126K | US$51.2M | 2.1% |
| Aveanna Healthcare Holdings Inc. | 3.87M | US$48M | 2.0% |
| Neurocrine Biosciences, Inc. | 337K | US$47.7M | 2.0% |
| Dianthus Therapeutics, Inc. | 518K | US$45.6M | 1.9% |
| BrightSpring Health Services, Inc. | 802K | US$45.5M | 1.9% |
| Generate Biomedicines, Inc. | 2.96M | US$44.5M | 1.8% |
| Maravai LifeSciences Holdings, Inc. | 5.5M | US$42.2M | 1.7% |
| Krystal Biotech, Inc. | 114K | US$37.9M | 1.6% |
| Acadia Healthcare Company, Inc. | 1.35M | US$37.2M | 1.5% |
| Alamar Biosciences, Inc. | 1.08M | US$36.9M | 1.5% |
| Kymera Therapeutics, Inc. | 301K | US$33.6M | 1.4% |
| Nuvectis Pharma, Inc. | 1.57M | US$33.2M | 1.4% |
| Climb Bio, Inc. | 2.86M | US$32.8M | 1.4% |
| Inspire Medical Systems, Inc. | 464K | US$32.2M | 1.3% |
| Danaher Corporation | 142K | US$31.4M | 1.3% |
| Maze Therapeutics, Inc. | 1.15M | US$31.2M | 1.3% |
| Humana Inc. | 81,399 | US$31.1M | 1.3% |
| Monte Rosa Therapeutics, Inc. | 2.53M | US$30.1M | 1.3% |
| Thermo Fisher Scientific Inc | 41,675 | US$28.1M | 1.2% |
| Immunocore Holdings plc | 906K | US$27.4M | 1.1% |
| Nektar Therapeutics | 444K | US$26.9M | 1.1% |
| Oruka Therapeutics, Inc. | 320K | US$26.6M | 1.1% |
| Boston Scientific Corporation | 588K | US$25.6M | 1.1% |
| Natera, Inc. | 59,900 | US$24.8M | 1.0% |
| Evolus, Inc. Common Stock | 3.08M | US$24.7M | 1.0% |
| Avalo Therapeutics, Inc. | 1.61M | US$24.7M | 1.0% |
| OrthoPediatrics Corp. | 1.1M | US$24.5M | 1.0% |
| Rhythm Pharmaceuticals, Inc. | 256K | US$24.4M | 1.0% |
| Bright Minds Biosciences Inc. | 484K | US$24.1M | 1.0% |
| MBX Biosciences, Inc. | 399K | US$23.4M | 0.97% |
| Corvus Pharmaceuticals, Inc. | 1.93M | US$22.2M | 0.92% |
| Repligen Corporation | 112K | US$21.4M | 0.89% |
| Avalyn Pharma Inc. | 744K | US$21.2M | 0.88% |
| Guardant Health, Inc. | 118K | US$21M | 0.87% |
| Nurix Therapeutics, Inc. | 871K | US$20.7M | 0.86% |
| Castle Biosciences, Inc. | 503K | US$17.9M | 0.74% |
| Ovid Therapeutics Inc. | 6.58M | US$16.4M | 0.68% |
| Stryker Corporation | 49,560 | US$13.6M | 0.57% |
| ORIC Pharmaceuticals, Inc. | 991K | US$13.3M | 0.55% |
| Septerna, Inc. | 328K | US$12.8M | 0.53% |
| Cogent Biosciences, Inc. | 401K | US$12.8M | 0.53% |
| Adlai Nortye Group Ltd. | 795K | US$12.7M | 0.53% |
| LifeStance Health Group, Inc. | 975K | US$11.7M | 0.49% |
| Zura Bio Limited | 2.65M | US$11M | 0.46% |
| Surrozen, Inc. | 335K | US$10.8M | 0.45% |
| Electra Therapeutics, Inc. | 906K | US$10.2M | 0.42% |
| Seaport Therapeutics, Inc. | 481K | US$9.71M | 0.40% |
| Helix Acquisition Corp. III | 900K | US$9.47M | 0.39% |
| Quest Diagnostics Incorporated | 40,400 | US$9.42M | 0.39% |
| Aclaris Therapeutics, Inc. | 1.75M | US$9.23M | 0.38% |
| Tectonic Therapeutic, Inc. | 371K | US$8.64M | 0.36% |
| Ionis Pharmaceuticals, Inc. | 176K | US$7.88M | 0.33% |
| Elevance Health, Inc. | 19,440 | US$7.56M | 0.31% |
| Amanat Acquisition Corp | 700K | US$7.46M | 0.31% |
| BioAge Labs, Inc. | 1.03M | US$7.32M | 0.30% |
| X4 Pharmaceuticals, Inc. | 2.34M | US$6.8M | 0.28% |
| Vor Biopharma Inc. | 319K | US$6.09M | 0.25% |
| Immunic, Inc. | 645K | US$6M | 0.25% |
| ADARx Pharmaceuticals, Inc. | 300K | US$5.98M | 0.25% |
| Research Alliance Corporation III | 400K | US$4.28M | 0.18% |
| JATT III Acquisition Corp | 350K | US$3.91M | 0.16% |
| Attovia Therapeutics, Inc. | 225K | US$3.86M | 0.16% |
| Research Alliance Corporation IV | 300K | US$3.55M | 0.15% |
| CG Oncology, Inc. | 41,100 | US$2.91M | 0.12% |
| JATT II Acquisition Corp | 250K | US$2.78M | 0.12% |
| Pulmonx Corporation | 753K | US$1.44M | 0.06% |
| Tenax Therapeutics, Inc. | 584K | US$1.1M | 0.05% |
| Hemab Therapeutics Holdings, Inc. | 0 | US$0 | 0.00% |
| Kardigan, Inc. | 0 | US$0 | 0.00% |
| MannKind Corporation | 0 | US$0 | 0.00% |
| VYNE Therapeutics Inc. | 0 | US$0 | 0.00% |
| Waters Corporation | 0 | US$0 | 0.00% |
| ACADIA Pharmaceuticals Inc. | 0 | US$0 | 0.00% |
| argenx SE | 0 | US$0 | 0.00% |
| CareDx, Inc. | 0 | US$0 | 0.00% |
| Celldex Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Cyclerion Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Damora Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Dyne Therapeutics, Inc. | 0 | US$0 | 0.00% |